share_log

Viracta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Murphy Samuel Lafayette

SEC ·  Jun 25, 2024 07:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more